SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
The Decline Of Venture Capital Investment In Early-Stage Life Sciences Poses A Challenge To Continued Innovation
1 references·7 citing·30 second hop
The Decline Of Venture Capital Investment In Early-Stage Life Sciences Poses A Challenge To Continued Innovation (2015)The Decline Of Venture Capital Investment…Trends in Risks Associated With New Drug Development: Success Rates for Investigational Drugs (2010)Trends in Risks Associated Wi…Financing agricultural innovation: Challenges and alternatives to venture capital in the AgTech sector (2025)Financing agricultural innova…Venture capital healthcare investments and health care sector growth: A panel data analysis of Europe (2021)Venture capital healthcare in…Regulatory review of new product innovation: Conceptual clarity and future research directions (2021)Regulatory review of new prod…Analysis of Venture Capital Investment in Therapeutic Otolaryngologic Devices, 2008-2017 (2019)Analysis of Venture Capital I…Stage-gate process for life sciences and medical innovation investment (2017)Stage-gate process for life s…How does venture capital operate in medical innovation? (2016)How does venture capital oper…How venture capitalists decide which new medical technologies come to exist (2015)How venture capitalists decid…The price of innovation: new estimates of drug development costs (2003)Can the pharmaceutical industry reduce attrition rates? (2004)Deconstructing the Drug Development Process: The New Face of Innovation (2010)Challenges and opportunities of drug repositioning (2013)Killer Acquisitions (2020)Critical junctures in the development of university high-tech spinout companies (2003)Picking winners or building them? Alliance, intellectual, and human capital as selection criteria in venture financing and performance of biotechnology startups (2003)Bridging Institutional Entrepreneurship and the Creation of New Organizational Forms: A Multilevel Model (2010)Biopharmaceutical pipeline funded by venture capital firms, 2014 to 2024 (2024)Research Design: Qualitative, Quantitative, and Mixed Methods Approaches (1994)Approaching adulthood: the maturing of institutional theory (2008)Converting clinical risks into economic value: The role of expectations and institutions in health technology development (2016)Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies (2017)21st Century Capitalism and Innovation for Health (2021)Technology in the Hospital: Transforming Patient Care in the Early Twentieth Century (1999)Physicians’ Views Of The Relative Importance Of Thirty Medical Innovations (2001)Basics of Qualitative Research (3rd ed.): Techniques and Procedures for Developing Grounded Theory (2008)Coevolution of cyberinfrastructure development and scientific progress (2020)From customer understanding to design for processability: Reconceptualizing the formal product innovation work process for non-assembled products (2023)Fueling Innovation In Medical Devices (And Beyond): Venture Capital In Health Care (2008)Association of the Meaningful Use Electronic Health Record Incentive Program With Health Information Technology Venture Capital Funding (2020)The role of venture capital in the creation of public companies (1990)The Effect of Health on Economic Growth: A Production Function Approach (2003)Disease and Development: The Effect of Life Expectancy on Economic Growth (2007)An Evolutionary Theory of Economic Change. (1983)Towards a Methodology for Developing Evidence‐Informed Management Knowledge by Means of Systematic Review (2003)Understanding dynamic capabilities (2003)The Discovery of Grounded Theory; Strategies for Qualitative Research (1968)Five Misunderstandings About Case-Study Research (2004)Seeking Qualitative Rigor in Inductive Research (2012)
this work references cited by second hop

References

  • 2010Trends in Risks Associated With New Drug Development: Success Rates for Investigational Drugs847 cited

Cited by

  • 2016How does venture capital operate in medical innovation?40 cited
  • 2015How venture capitalists decide which new medical technologies come to exist35 cited
  • 2017Stage-gate process for life sciences and medical innovation investment34 cited
  • 2021Regulatory review of new product innovation: Conceptual clarity and future research directions26 cited
  • 2021Venture capital healthcare investments and health care sector growth: A panel data analysis of Europe18 cited
  • 2019Analysis of Venture Capital Investment in Therapeutic Otolaryngologic Devices, 2008-201714 cited
  • 2025Financing agricultural innovation: Challenges and alternatives to venture capital in the AgTech sector13 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work